BPC-157 10mg · Research brief
Where to Buy BPC 157 Peptide — Vials, COAs, Ordering
Short answer
Finding a seller for BPC-157 takes about four seconds. Proving that the white cake at the bottom of the vial is actually the 15-amino-acid sequence printed on the label takes documentation that most sellers never publish. That gap is where nearly every bad purchase in this category happens.
Key takeaways
- BPC-157 is a 15-amino-acid pentadecapeptide with a molecular weight of approximately 1419.5 Da and CAS number 137525-51-0, and both values should appear in supplier documentation.
- HPLC purity confirms homogeneity, not identity; only mass spectrometry confirms that the peak in the chromatogram is actually BPC-157.
- A certificate of analysis is worthless unless the lot number on it matches the lot number printed on the vial you received.
- Anyone planning to buy bpc 157 peptide should treat publicly posted, third-party certificates as the minimum standard rather than a bonus feature.
- BPC-157 is not an FDA-approved drug, sits in FDA Category 2 of the bulk drug substances review, and has been on the WADA Prohibited List under class S0 since 2022.
- Real Peptides supplies BPC-157 as a lyophilized research vial and in capsule format, with batch documentation, and provides no dosing or preparation guidance because these are research-use-only compounds.
Finding a seller for BPC-157 takes about four seconds. Proving that the white cake at the bottom of the vial is actually the 15-amino-acid sequence printed on the label takes documentation that most sellers never publish. That gap is where nearly every bad purchase in this category happens.
Our team works with laboratories that buy bpc 157 peptide for in vitro and animal-model work, and the pattern repeats: the compound is rarely the problem. The paperwork is.
Where can you buy BPC 157 peptide for laboratory research?
You can buy BPC 157 peptide from research suppliers that publish batch-specific certificates of analysis confirming both HPLC purity, commonly stated at 98% or higher, and molecular identity by mass spectrometry against a mass of roughly 1419.5 Da. Match the lot number on the certificate to the lot printed on the vial before ordering.
The common oversimplification is that a high purity percentage equals a good product. It doesn't. HPLC purity describes how much of a sample elutes as a single peak, not whether that peak is BPC-157, so identity has to come from mass spectrometry and a matching CAS registry number. This piece covers what the published literature actually reports, how to read a certificate line by line, how vial and capsule formats differ, and what a legitimate ordering process looks like.
The pentadecapeptide behind the label
BPC-157 is a synthetic pentadecapeptide, a chain of 15 amino acids in the sequence GEPPPGKPADDAGLV, derived from a partial sequence of body protection compound, a protein originally isolated from human gastric juice. Its molecular weight is approximately 1419.5 Da and its CAS registry number is 137525-51-0. Those two values are the compound's identity fingerprint. A supplier page that omits both is telling you something useful.
The published literature, most of it from rodent models and cell culture produced by the University of Zagreb group that first characterized the peptide, reports effects on angiogenic signaling through VEGFR2, the vascular endothelial growth factor receptor that drives new capillary formation, with downstream involvement of the Akt and eNOS pathway. eNOS stands for endothelial nitric oxide synthase, the enzyme that generates nitric oxide in blood vessel walls. Other in vitro work describes increased tendon fibroblast outgrowth and changes in FAK-paxillin signaling, the adhesion pathway cells use to migrate across a surface.
Human data remains thin. A small number of early-phase studies have been registered, and the compound is still investigational rather than approved anywhere as a drug product.
In our experience supplying research labs, the groups that generate reproducible data are the ones that log a batch number next to every result. Before anyone should buy bpc 157 peptide for a study that has to stand up to review, those identity markers need to be verifiable on paper.
Reading a certificate of analysis the way a chemist does
A certificate of analysis is only useful if it is batch-specific, dated, and issued against the exact lot number printed on your vial. Most buyers check that a certificate exists. That is the wrong check.
Here is the mistake most sourcing guides get wrong. They treat HPLC purity as the headline number. High-performance liquid chromatography separates a sample by how its components travel through a column and reports what fraction elutes as one peak. A 99% figure means 99% of the material is a single substance. It says nothing about which substance. Identity comes from mass spectrometry, which measures the mass-to-charge ratio of the molecule and should resolve to roughly 1419.5 Da for this sequence. A vial of a cheaper, structurally unrelated peptide can produce a perfectly clean 99% HPLC trace.
So read in this order: lot number match, mass spectrometry identity, HPLC purity, test date, and the name of the laboratory that ran the analysis. Third-party testing carries weight that in-house testing does not, and certificates posted publicly carry more weight than certificates emailed on request after payment.
Our team has reviewed enough supplier documentation to spot the tell instantly: a certificate with no lot number, or a lot number that appears on every product in the catalog. Researchers who buy bpc 157 peptide regularly build one small habit. Photograph the vial label, match it to the posted certificate, file both with the study notes.
Vials, capsules, and what 'injectable' means in a research catalog
Searches for 'buy bpc 157 injectable' almost always resolve to one physical product: a lyophilized powder sealed in a glass vial for laboratory use. Lyophilization is freeze-drying under vacuum, which removes water so the peptide holds its structure as a dry cake far longer than it would in solution. Vials are commonly supplied in 5mg or 10mg presentations, and the Real Peptides catalog vial is 10mg.
Queries for 'buy bpc-157 capsules' point to an oral research format, where the peptide is encapsulated instead of vialed as loose powder. The research interest in oral presentations traces back to reports of the peptide's relative stability in gastric juice, which is unusual for a peptide of this size. Both formats are research use only and neither is intended for human or veterinary consumption.
Real Peptides does not publish preparation, volume, or dosing guidance, and no legitimate research supplier should. The only measurement framework that belongs on a supplier page is concentration math: total milligrams stated on the certificate divided by total millilitres of solvent gives milligrams per millilitre. Everything beyond that number belongs to the study protocol and the institution running it.
That's also why researchers looking to buy bpc 157 peptide injections online will find that credible suppliers describe the vial contents, the purity data, and the storage conditions, then stop talking.
Ordering, cold chain, and regulatory status
A legitimate research order should carry three things: a research-use-only attestation at checkout, batch traceability from synthesis through to shipment, and insulated packaging that limits temperature swings in transit. Lyophilized peptide is comparatively forgiving of brief ambient exposure during shipping. Material in solution is not, which is why dry vials are the standard research format.
Long-term storage of lyophilized vials is typically at -20degC, protected from light and moisture, with the vial seal left intact until the study calls for it. Small-batch synthesis matters here for a practical reason rather than a marketing one: smaller lots mean the certificate you are reading describes a defined quantity of material, not a blended pool of production runs.
The regulatory picture should shape your expectations of any seller. BPC-157 is not an FDA-approved drug. In 2023 the FDA placed it in Category 2 of its bulk drug substances review, the category for substances flagged with significant safety risks for use in compounding, and the World Anti-Doping Agency added BPC-157 to its Prohibited List in 2022 under the S0 non-approved substances class. Neither fact prevents laboratory procurement. Both mean any supplier making therapeutic claims is signalling that they do not understand the regulatory frame they operate in.
The information here is educational and describes laboratory research context only. All compounds referenced are supplied for research use, not for human consumption.
Buy BPC 157 Peptide: Vial, Capsule and Listing Comparison
Format determines what documentation you should demand and what a batch can realistically prove. This table maps the three presentations researchers encounter, plus the listing type worth walking away from.
| Format | Physical state and storage | Documentation to demand | Typical research context | Bottom Line |
|---|---|---|---|---|
| Lyophilized vial (10mg) | Dry cake under vacuum seal, stored at -20degC, light-protected | Batch COA with lot match, mass spec near 1419.5 Da, HPLC purity, test date, lab name | In vitro and animal-model studies where concentration must be calculated from stated vial contents | The reference format. Best traceability and longest stable shelf life of any presentation. |
| Oral capsule format | Encapsulated solid, ambient or cool dry storage per label | COA for the peptide lot used, plus stated milligram content per capsule | Studies examining oral presentation of a peptide reported to tolerate gastric conditions | Legitimate research format, but verify the peptide lot behind the capsule, not just the capsule label. |
| Pre-mixed solution listing | Liquid, requires consistent refrigeration through the entire supply chain | COA plus stability and concentration data for the solution as shipped | Rare in research procurement because in-transit temperature history cannot be verified | Avoid unless the supplier documents cold chain end to end. Solution stability is the weak link. |
| Unlabeled marketplace listing | Unknown, frequently repackaged with no lot identity | Usually none, or a generic certificate reused across products | None that would survive peer review | Not research material. No lot, no identity, no data you can defend. |
What If: Sourcing and Verification Scenarios
What if the supplier won't share a certificate of analysis before purchase?
Walk away and source elsewhere. Batch documentation costs a supplier nothing to publish once the testing is already done, so refusal usually means testing was never commissioned for that lot, or a single old certificate is being reused across multiple production runs. Suppliers who commission third-party analysis treat those certificates as their strongest sales asset and post them openly. A promise to send documentation after payment reverses the entire logic of verification.
What if the certificate lists a purity percentage but no mass spectrometry data?
Request the mass spec report for that specific lot before ordering. Purity alone cannot distinguish BPC-157 from a different peptide synthesized cleanly, because chromatography measures separation, not molecular identity. Mass spectrometry should return a value close to 1419.5 Da for this sequence. If a supplier can produce HPLC data but not mass spec data, the practical reading is that identity was never independently confirmed on that batch.
What if the lyophilized cake looks broken or stuck to the vial wall?
Document it with a photograph and contact the supplier with the lot number before doing anything else. Lyophilized cakes commonly shift, fracture, or cling to the glass during shipping, and physical displacement alone does not indicate degradation. What matters more is whether the vial seal is intact and whether the powder shows discoloration or visible moisture. A compromised seal is the real failure condition and warrants replacement, not judgement calls.
What if one listing is priced far below every other supplier?
Treat the price gap as a documentation question rather than a bargain. Peptide synthesis, purification, and third-party analytical testing carry fixed costs, and a price well below the market usually reflects an omitted step: no independent testing, blended lots, underfilled vials, or a shorter sequence that costs less to make. Compare the certificate first. If the cheap listing has no lot-matched mass spec data, you are not comparing the same product.
The Uncomfortable Truth About Sourcing This Compound
Here's the honest answer: most of what is sold online as BPC-157 has never been independently tested, and the buyer has no way to know. The research literature describing this peptide is genuinely interesting, largely preclinical, and still short on human data. Marketing copy that skips past that and promises outcomes is not just non-compliant, it is a direct signal that the seller isn't reading the papers. Judge suppliers on one axis only: can they show you a lot-matched, third-party certificate with a mass value near 1419.5 Da? Everything else is decoration.
Researchers comparing formats can review the lyophilized BPC-157 10mg vial or the BPC-157 capsule format, read the compound background on our BPC-157 research page, check batch documentation in our published COA library, browse the full research catalog, or review our locations and shipping information.
Wherever you buy bpc 157 peptide, the vial itself is the cheapest part of the transaction. What you are really paying for is a chain of evidence: a synthesis batch that was tested, a certificate that names the laboratory and the lot, and a measured mass that lands where the sequence says it should. Research that cannot trace its material back to that chain isn't research, it's anecdote with a pipette. This peptide has been studied for roughly three decades. The documentation standard around it is what is still catching up.
References
Peer-reviewed sources on BPC-157 indexed in PubMed, listed for research context. Real Peptides supplies BPC-157 for laboratory research use only.
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 2025. PMID 40756949. doi:10.1177/15563316251355551
- Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals (Basel, Switzerland), 2025. PMID 40005999. doi:10.3390/ph18020185
- Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Current reviews in musculoskeletal medicine, 2025. PMID 40789979. doi:10.1007/s12178-025-09990-7
- Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats-A Review. Pharmaceuticals (Basel, Switzerland), 2024. PMID 39204186. doi:10.3390/ph17081081
- From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management. International journal of molecular sciences, 2026. PMID 41898733. doi:10.3390/ijms27062876
- BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase. International journal of molecular sciences, 2026. PMID 42278509. doi:10.3390/ijms27114984
- Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury. Scientific reports, 2026. PMID 42204242. doi:10.1038/s41598-026-55449-1
- Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study. Joint diseases and related surgery, 2026. PMID 42542926. doi:10.52312/jdrs.2026.2951
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add doses.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA